24 related articles for article (PubMed ID: 8789674)
1. Limitation of stunning in dog myocardium by nucleoside and nucleotide mixture, OG-VI.
Ichihara K; Kano S; Satoh K; Nakai T; Fukutomi T; Okazaki Y; Kohri H
Nutrition; 1997 May; 13(5):462-4. PubMed ID: 9225340
[TBL] [Abstract][Full Text] [Related]
2. Effects of OG-VI, a nucleoside/nucleotide mixture, on stunned myocardium in dogs: is the adenosine A1 receptor involved?
Kano S; Satoh K; Hoshi K; Ichihara K
Coron Artery Dis; 1998; 9(1):29-34. PubMed ID: 9589188
[TBL] [Abstract][Full Text] [Related]
3. Limitation of stunning in dog myocardium by nucleoside and nucleotide mixture, OG-VI.
Satoh K; Nakai T; Hoshi K; Ichihara K
Coron Artery Dis; 1993 Nov; 4(11):1007-12. PubMed ID: 8173706
[TBL] [Abstract][Full Text] [Related]
4. Effects of pimobendan and EGIS 9377, cardiotonic agents, and OG-VI, a nucleoside-nucleotide mixture, administered during reperfusion after ischemia on stunned myocardium in dogs.
Fukutomi T; Satoh K; Ogoshi S; Ichihara K
Coron Artery Dis; 2000 Feb; 11(1):83-90. PubMed ID: 10715811
[TBL] [Abstract][Full Text] [Related]
5. Effects of OG-VI, a nucleoside-nucleotide mixture, on ischemic myocardial metabolism in dogs.
Okazaki Y; Kano S; Ogoshi S; Ichihara K
Coron Artery Dis; 1997 Jan; 8(1):39-43. PubMed ID: 9101121
[TBL] [Abstract][Full Text] [Related]
6. The well-balanced nucleoside-nucleotide mixture "OG-VI" for special medical purposes.
Iwasa Y; Iwasa M; Omori Y; Toki T; Yamamoto A; Maeda H; Kume M; Ogoshi S
Nutrition; 1997 Apr; 13(4):361-4. PubMed ID: 9178288
[TBL] [Abstract][Full Text] [Related]
7. Acadesine: the prototype adenosine regulating agent for reducing myocardial ischaemic injury.
Mullane K
Cardiovasc Res; 1993 Jan; 27(1):43-7. PubMed ID: 8458030
[TBL] [Abstract][Full Text] [Related]
8. Effect of verapamil on postischemic "stunned" myocardium: importance of the timing of treatment.
Przyklenk K; Kloner RA
J Am Coll Cardiol; 1988 Mar; 11(3):614-23. PubMed ID: 3278036
[TBL] [Abstract][Full Text] [Related]
9. Pharmacologic treatment of the stunned myocardium: the concepts and the challenges.
Przyklenk K
Coron Artery Dis; 2001 Aug; 12(5):363-9. PubMed ID: 11491201
[TBL] [Abstract][Full Text] [Related]
10. Smerter. Baggrund, evidens og behandling.
Breivik H
Scand J Pain; 2019 Jul; 19(4):857. PubMed ID: 31352435
[No Abstract] [Full Text] [Related]
11. Effects of OG-VI, a nucleoside/nucleotide mixture, and its constituents on myocardial stunning in dogs.
Kano S; Nakai T; Kohri H; Ichihara K
Coron Artery Dis; 1995 Oct; 6(10):811-8. PubMed ID: 8789674
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
